Oncology - Soft Tissue/Sarcoma News & Articles

Looking for the latest in oncology clinical literature? You've found the right page. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the articles they think will make a difference to you and your practice. You'll find them organized here by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants and the whole cancer care team can stay current on the literature as it is published.

On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We feature clinical pearls as well, from The Smartest Oncologist to oncology topics in The Smartest Pediatrician daily quiz challenges.

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Smartest Doc Challenge
MDLinx
Today Only! We’re helping you prep for your board exams

D Scott Cunningham MD, PhD
Site Editor, MDLinx
Markers of obesity and inflammation in postmenopausal breast cancer

Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage

MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools

MDLinx Top Read
MDLinx
Running from that pile of unread journals?

New!	>> Find out who is the Smartest Doc in Oncology!

Articles

Latest (1) Full Text Articles (114) Focus on Pediatric

Ranked, sorted, and summarized by MDLinx editors from the latest literature

Topics:

1 Galectin-1 (GAL-1) expression is a useful tool to differentiate between small cell osteosarcoma and Ewing sarcoma Virchows Archiv, May 22, 2013 Clinical Article

Prior Articles

2 Transcutaneous electrical nerve stimulation for treatment of sarcoma cancer pain Pain Management, May 20, 2013 Clinical Article

3 Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis Journal of Clinical Oncology, May 17, 2013 Review Article

4 Expression of FGFR3 and FGFR4 and clinical risk factors associated with progression-free survival in synovial sarcoma Human Pathology, May 16, 2013 Clinical Article

5 TGF-β1 suppression of microRNA-450b-5p expression: a novel mechanism for blocking myogenic differentiation of rhabdomyosarcoma Oncogene, May 15, 2013 Clinical Article

6 Molecular Distinction of Chondrosarcoma From Chondroblastic Osteosarcoma Through IDH1/2 Mutations American Journal of Surgical Pathology , May 15, 2013 Clinical Article

7 The strength of small: Improved targeting of Insulin-like Growth Factor-1 Receptor (IGF-1R) with F(ab')2-R1507 fragments in Ewing sarcomas European Journal of Cancer, May 14, 2013 Clinical Article

8 Regulation of Target Genes of PAX3-FOXO1 in Alveolar Rhabdomyosarcoma Anticancer Research, May 14, 2013 Clinical Article

9 Targeting FoxM1 Effectively Retards p53-Null Lymphoma and Sarcoma Molecular Cancer Therapeutics, May 14, 2013 Clinical Article

10 Spinal anaesthesia for caesarean section in the presence of respiratory failure and spinal metastases from a soft tissue clear cell sarcoma International Journal of Obstetric Anesthesia , May 14, 2013

11 Carcinosarcoma of the liver: report of a case Surgery Today, May 13, 2013 Review Article

12 HMGA2-IGF2BP2 Regulates NRAS in Rhabdomyosarcoma Cancer Research, May 10, 2013 Review Article

13 Follicle-stimulating hormone receptor expression in soft tissue sarcomas Histopathology, May 10, 2013 Clinical Article

14 CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity Oncogene, May 8, 2013 Clinical Article

15 Cediranib for Metastatic Alveolar Soft Part Sarcoma Journal of Clinical Oncology, May 6, 2013 Clinical Article

16 Frequent PLAG1 gene rearrangements in skin and soft tissue myoepithelioma with ductal differentiation Genes, Chromosomes and Cancer, May 3, 2013 Clinical Article

17 LGR5 is Expressed by Ewing Sarcoma and Potentiates Wnt/β-Catenin Signaling Frontiers in Oncology, May 3, 2013 Clinical Article

18 Survival of pediatric patients after relapsed osteosarcoma: The St. Jude Childrens Research Hospital experience Cancer, May 2, 2013

19 Clinical report on transarterial neoadjuvant chemotherapy of malignant fibrous histiocytoma in soft tissue Clinical and Translational Oncology, May 2, 2013 Review Article Clinical Article

20 EWSR1-CREB3L1 Gene Fusion: A Novel Alternative Molecular Aberration of Low-grade Fibromyxoid Sarcoma American Journal of Surgical Pathology , May 2, 2013

50 available pages FirstPrevious 1 2 3 4 5 6 7 8 9 10 Next Last

Clinical Pearls in Oncology

The ZORO study demonstrated that the addition of goserelin to neoadjuvant chemotherapy for early breast cancer in premenopausal women resulted in no change in post-chemotherapy rates of amenorrhea
A little over 50% of tumors in women with ER-positive, node-negative breast cancers will have a RS <18, and current data suggests that these women are UNLIKELY to receive a benefit from adjuvant chemotherapy
In patients with completely resected ER-positive DCIS when the surgical specimen also has LCIS, consider breast MRI screening in addition to mammography due to the lower sensitivity of mammograms for lobular disease

» Test your knowledge. Take the Smartest Doc challenge today!

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.

Read the article summary

HCC risk increased in patients with AIDS

As reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.

Read the article summary

RAB25 is a prognostic marker for ovarian cancer

As reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Oncology Articles

Last month's top read Top Articles of 2012

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncology more

Enter your email address and your password will be sent to you.
Email:

E-mail:
Password:
	Remember me Forgot your password?

Oncology - Soft Tissue/Sarcoma News & Articles

Articles

Prior Articles

Clinical Pearls in Oncology

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

HCC risk increased in patients with AIDS

RAB25 is a prognostic marker for ovarian cancer

Most Popular Oncology Articles

Other Topics in Oncology